Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katelyn Varieur"'
Autor:
Lola Rahib, Mark T. Curtis, Joseph Bender, Jonathan R. Brody, Craig Heartwell, Stephen C. Peiper, Charles J. Yeo, Cinthya S. Yabar, Katelyn Varieur, Mahsa Zarei, Zi-Xuan Wang, Jordan M. Winter, Lynn M. Matrisian, Subha Madhavan, Wei Jiang, Kimberly Mason, Danielle Fortuna, Michael J. Pishvaian, Emanuel F. Petricoin
Publikováno v:
Cancer Biology & Therapy. 19:249-253
Isocitrate dehydrogenase 1 (IDH1) is a metabolic enzyme implicated in cancer cell metabolic reprogramming. This is underscored by the detection of functional, somatic IDH1 mutations frequently found in secondary glioblastoma. To our knowledge, there
Autor:
Lynn M. Matrisian, Kimberly Mason, William Arthur Hoos, Michael J. Pishvaian, Andrew Eugene Hendifar, R Joseph Bender, Jonathan R. Brody, Sam Mikhail, Subha Madhavan, Lola Rahib, Emanuel F. Petricoin, Vincent J. Picozzi, Katelyn Varieur, Vincent Chung, Metasebia Aberra, Craig Heartwell
Publikováno v:
Oncotarget, vol 8, iss 48
Oncotarget
Oncotarget
// Michael J. Pishvaian 1,2,* , R. Joseph Bender 1,* , Lynn M. Matrisian 3 , Lola Rahib 3 , Andrew Hendifar 4 , William A. Hoos 3 , Sam Mikhail 5 , Vincent Chung 6 , Vincent Picozzi 7 , Craig Heartwell 1 , Kimberly Mason 1 , Katelyn Varieur 1 , Metas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f088edb8aee38c5b96c46310b22ecf2
https://escholarship.org/uc/item/8q82b7nd
https://escholarship.org/uc/item/8q82b7nd
Autor:
Subha Madhavan, William Arthur Hoos, Katelyn Varieur, Andrew Eugene Hendifar, Metasebia Aberra, R Joseph Bender, Michael J. Pishvaian, Sameh Mikhail, Kimberly Mason, Craig Heartwell, Linlin Luo, David Halverson, Emanuel F. Petricoin, Vincent Chung, Corinne Ramos, Jonathan R. Brody, Lynn M. Matrisian, Lola Rahib, Vincent J. Picozzi
Publikováno v:
Journal of Clinical Oncology. 35:278-278
278 Background: Recent studies have expanded our knowledge of the genomic landscape of PDA. While critical and in some cases, potentially actionable alterations are being identified, limited outcomes data have thus far made it difficult to validate t
Autor:
Michael J. Pishvaian, Sameh Mikhail, Subha Madhavan, Jonathan R. Brody, Craig Heartwell, Anitra Engebretson, Andrew Eugene Hendifar, Lynn M. Matrisian, Kimberly Mason, Vincent J. Picozzi, Katelyn Varieur, Vincent Chung, William Arthur Hoos, Emanuel F. Petricoin, Lola Rahib
Publikováno v:
Journal of Clinical Oncology. 34:279-279
279 Background: There has been a significant increase in the utilization of MoP to facilitate the selection of therapies for pts with advanced cancers. However, coordinated efforts to perform uniform MoP and collect clinical outcomes data have only s
Autor:
Michael J. Pishvaian, Andrew Eugene Hendifar, Sameh Mikhail, Kimberly Mason, Katelyn Varieur, Jonathan R. Brody, Lola Rahib, William Arthur Hoos, Subha Madhavan, Vincent Chung, Craig Heartwell, Anitra Engebretson, Vincent J. Picozzi, Emanuel F. Petricoin, Lynn M. Matrisian
Publikováno v:
Journal of Clinical Oncology. 34:268-268
268 Background: Obtaining an adequate tissue sample for molecular profiling to guide therapy selection for patients with advanced cancers can be clinically difficult, and/or patients may not want to undergo a biopsy. There has been a growing interest